ArticleAmerican journal of translational research2025
Clinical effectiveness of Anlotinib combined with PD-1 inhibitors in treating advanced non-small-cell lung carcinoma.
Zhaoqing Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.